Encentrio Therapeutics, Inc.

Biotechnology company · San Francisco, California, United States

Encentrio Therapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $400,000 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Encentrio Therapeutics at a glance

Typebiotechnology company

HeadquartersSan Francisco, California, United States

Earliest incorporation on record2023

SEC CIK1971101

What does Encentrio Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $400,000 sold (2023).

Frequently asked questions about Encentrio Therapeutics

Where is Encentrio Therapeutics headquartered?

Encentrio Therapeutics, Inc. is headquartered in San Francisco, California, United States.

What does Encentrio Therapeutics do?

Encentrio Therapeutics, Inc. is a biotechnology company.

When was Encentrio Therapeutics founded?

The earliest incorporation on record for Encentrio Therapeutics, Inc. is in 2023, according to public company registers.

Similar companies

Ossium Health, Inc.San Francisco, California, United States
Vir Biotechnology, Inc.San Francisco, California, United States
Titan Pharmaceuticals IncSan Francisco, California, United States
Senti Biosciences, Inc.San Francisco, California, United States
Amygdala Neurosciences IncSan Francisco, California, United States
Excision BioTherapeutics IncSan Francisco, California, United States
ProLynx, Inc.San Francisco, California, United States
Second Genome, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences